HuGE Literature Finder
Records
1
-
5
| Effect of multiple-dose osimertinib on the pharmacokinetics of simvastatin and rosuvastatin. British journal of clinical pharmacology 2018 Sep . Donald Harvey R, Aransay Noemi Reguart, Isambert Nicolas, Lee Jong-Seok, Arkenau Tobias, Vansteenkiste Johan, Dickinson Paul A, Bui Khanh, Weilert Doris, So Karen, Thomas Karen, Vishwanathan Karthi |
| Cytochrome P450 Allele CYP3A7*1C Associates with Adverse Outcomes in Chronic Lymphocytic Leukemia, Breast, and Lung Cancer. Cancer research 2016 Mar 76 (6): 1485-93. Johnson Nichola, De Ieso Paolo, Migliorini Gabriele, Orr Nick, Broderick Peter, Catovsky Daniel, Matakidou Athena, Eisen Timothy, Goldsmith Christy, Dudbridge Frank, Peto Julian, Dos-Santos-Silva Isabel, Ashworth Alan, Ross Gillian, Houlston Richard S, Fletcher Oliv |
| Erlotinib in African Americans with advanced non-small cell lung cancer: a prospective randomized study with genetic and pharmacokinetic analyses. Clinical pharmacology and therapeutics 2014 Aug 96 (2): 182-91. Phelps M A, Stinchcombe T E, Blachly J S, Zhao W, Schaaf L J, Starrett S L, Wei L, Poi M, Wang D, Papp A, Aimiuwu J, Gao Y, Li J, Otterson G A, Hicks W J, Socinski M A, Villalona-Calero M |
| Genotype relationships in the CYP3A locus in Caucasians. Cancer letters 2004 Apr 207 (1): 95-9. Dally Heike, Bartsch Helmut, Jäger Birgit, Edler Lutz, Schmezer Peter, Spiegelhalder Bertold, Dienemann Hendrik, Drings Peter, Kayser Klaus, Schulz Volker, Risch Ange |
| The CYP3A4*1B allele increases risk for small cell lung cancer: effect of gender and smoking dose. Pharmacogenetics 2003 Oct 13 (10): 607-18. Dally Heike, Edler Lutz, Jäger Birgit, Schmezer Peter, Spiegelhalder Bertold, Dienemann Hendrik, Drings Peter, Schulz Volker, Kayser Klaus, Bartsch Helmut, Risch Ange |
- Page last reviewed:Jul 25, 2022
- Page last updated:Aug 03, 2022
- Content source: